PGEN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
74.1M
+34.9%
55.0M
+136.4%
23.3M
+409.4%
4.6M
+56.2%
2.9M
Cost of Revenue
6.5M
+132.0%
2.8M
+9.6%
2.6M
+60.3%
1.6M
+54.2%
1.0M
Gross Profit
67.6M
+29.6%
52.2M
+152.1%
20.7M
+597.0%
3.0M
+57.3%
1.9M
Operating Expenses
29.0M
-1.8%
29.5M
+10.7%
26.7M
+8.3%
24.6M
-32.3%
36.4M
R&D
6.6M
-8.9%
7.3M
+29.2%
5.6M
-19.3%
7.0M
-43.5%
12.4M
SG&A
22.4M
+0.5%
22.2M
+5.7%
21.0M
+19.3%
17.6M
-26.5%
24.0M
Operating Income
38.6M
+70.7%
22.6M
+477.7%
-5994000
+72.3%
-21666000
+37.2%
-34481000
EBITDA
39.8M
+67.5%
23.7M
+585.0%
-4895000
+76.2%
-20529000
+39.0%
-33678000
Net Income
35.8M
+78.2%
20.1M
+353.1%
-7929000
+66.3%
-23503000
+83.9%
-146344000
EPS (Basic)
$0.10
+66.7%
$0.06
+400.0%
$-0.02
+71.4%
$-0.07
+93.4%
$-1.06
EPS (Diluted)
$0.08
+60.0%
$0.05
+350.0%
$-0.02
+71.4%
$-0.07
+93.4%
$-1.06
Shares (Diluted)
421.2M
+1.8%
413.7M
+16.8%
354.3M
-0.0%
354.4M
+15.4%
307.2M
Precigen (PGEN) — Financials